LPCAT2 and breast cancer: As shown in Fig. 2A, high expression of NT5E, RAP1GAP2, SDPR, SCEL, LPCAT2, SMURF2, and CTGF were significantly associated with the poor survival of BC patients among the candidate proteins (Fig. 2A).